ALFA Filings
Every announcement, straight from the exchange
Every Neuland Laboratories results update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Neuland Laboratories' Q2 FY27 standalone revenue fell 11.4% YoY to Rs. 457.2 Crore, with PAT at Rs. 51.1 Crore. The release lacks a full results statement.
Neuland Laboratories reported Q1 FY27 total income of ₹650.1 crore and EBITDA of ₹231.1 crore. The company highlights strong performance across CMS and GDS businesses.
Neuland Laboratories reported FY26 total income of ₹2053.1 Crore and EBITDA of ₹603.4 Crore. Annual performance shows strong execution discipline and positive business visibility.